<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Item #</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1420</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">SEER/CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2249 - 2249</td>
    </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.rxSummOther<br/><br/>
<strong>Alternate Names</strong>
<br/>&nbsp;&nbsp;&nbsp;Other Treatment (CoC)
<br/>&nbsp;&nbsp;&nbsp;Other Cancer-Directed Therapy (SEER/pre-96 CoC)


<div class='content chap10-para-head'><strong><strong>Description</strong></strong></div>
<div class='content chap10-para mark-changed'>Identifies other treatment given at all facilities that cannot be defined as surgery, radiation, or systemic therapy according to the defined data items in this manual. Treatment for reportable hematopoietic diseases can be supportive care, observation, or any treatment that does not meet the usual definition in which treatment modifies, controls, removes, or destroys proliferating cancer tissue. Such treatments include phlebotomy, transfusions, and aspirin.</div>
<div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div>
<div class='content chap10-para mark-changed'>Information on other therapy is used to describe and evaluate the quality-of-care and treatment practices.</div>
<div class='content chap10-para mark-changed'><strong>Codes (Refer to the most recent version of <em>STORE</em> for additional coding instructions) </strong></div>
<div class='content chap10-para'>
    <table>
        <tr class='code-row'>
            <td class='code-nbr'>0</td>
            <td class='code-desc'>None</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>1</td>
            <td class='code-desc'>Other</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>2</td>
            <td class='code-desc'>Other Experimental</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>3</td>
            <td class='code-desc'>Other-Double Blind</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>6</td>
            <td class='code-desc'>Other-Unproven</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>7</td>
            <td class='code-desc'>Refusal</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>8</td>
            <td class='code-desc'>Recommended</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>9</td>
            <td class='code-desc'>Unknown; unknown if administered</td>
        </tr>
    </table>
</div>